ORCA Therapeutics

ORCA Therapeutics is a biopharmaceutical company designing and developing immunotherapies for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA). It utilizes proprietary technologies to engineer oncolytic adenoviruses that selectively kill cancer cells and induce an antitumor immune response.